MAPT and Alzheimer disease: Subsequent studies by Farias et al. (15), have shown that there is a close correlation between the degree of platelet tau modification and level of cognitive impairment, which was measured using neuropsychological tests in patients with AD [for more detailed information about these biomarkers see Ref.